BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 20077420)

  • 21. Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1.
    Oh WK; Cho KB; Hien TT; Kim TH; Kim HS; Dao TT; Han HK; Kwon SM; Ahn SG; Yoon JH; Kim TH; Kim YG; Kang KW
    Mol Pharmacol; 2010 Nov; 78(5):855-64. PubMed ID: 20713551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB.
    Bark H; Choi CH
    Cancer Chemother Pharmacol; 2010 May; 65(6):1131-6. PubMed ID: 19763573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
    Yamagishi N; Nakao R; Kondo R; Nishitsuji M; Saito Y; Kuga T; Hatayama T; Nakayama Y
    Biochem Biophys Res Commun; 2014 Jun; 448(4):430-6. PubMed ID: 24796664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
    Kang Y; Park MA; Heo SW; Park SY; Kang KW; Park PH; Kim JA
    Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line.
    Lin X; Zhang X; Wang Q; Li J; Zhang P; Zhao M; Li X
    Neoplasma; 2012; 59(3):248-56. PubMed ID: 22329846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular mechanism of reversing multi-drug resistance of K562/AO2 by puerarin].
    Chen JW; Tao S; Luo R; Zhang GS; Xu YX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):216-21. PubMed ID: 18382055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Puerarin inhibits adhesion molecule expression in tnf-alpha-stimulated human endothelial cells via modulation of the nuclear factor kappaB pathway.
    Hu W; Zhang Q; Yang X; Wang Y; Sun L
    Pharmacology; 2010; 85(1):27-35. PubMed ID: 20016245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. γ-Tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the γ-Tocotrienol-NF-κB-P-gp axis.
    Ding Y; Fan J; Fan Z; Zhang K
    J Steroid Biochem Mol Biol; 2021 May; 209():105835. PubMed ID: 33556581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
    Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC
    Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Puerarin inhibits C-reactive protein expression via suppression of nuclear factor kappaB activation in lipopolysaccharide-induced peripheral blood mononuclear cells of patients with stable angina pectoris.
    Yang X; Hu W; Zhang Q; Wang Y; Sun L
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):637-42. PubMed ID: 20346059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
    Xu D; Lu Q; Hu X
    Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells.
    Li Y; Sun Y; Tang T; Niu Y; Li X; Xie M; Jin H; Mei Q
    J Ethnopharmacol; 2019 Mar; 232():47-54. PubMed ID: 30552993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver.
    Horike N; Sakoda H; Kushiyama A; Ono H; Fujishiro M; Kamata H; Nishiyama K; Uchijima Y; Kurihara Y; Kurihara H; Asano T
    J Biol Chem; 2008 Dec; 283(49):33902-10. PubMed ID: 18801732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycyrrhizin induces melanogenesis by elevating a cAMP level in b16 melanoma cells.
    Lee J; Jung E; Park J; Jung K; Park E; Kim J; Hong S; Park J; Park S; Lee S; Park D
    J Invest Dermatol; 2005 Feb; 124(2):405-11. PubMed ID: 15675961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
    Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a novel photoactivated photosensitizer on MDR1 over-expressing human breast cancer cells.
    Chen JJ; Liu SP; Zhao J; Wang SC; Liu TJ; Li X
    J Photochem Photobiol B; 2017 Jun; 171():67-74. PubMed ID: 28478351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.